Search

Search Constraints

You searched for: Author/Creator Lee, Jessica

Search Results

81. Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies. Issue 5 (23rd October 2020)

82. Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies. Issue 5 (23rd October 2020)

84. Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial. (January 2021)

85. Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial. Issue 10008 (21st November 2015)

86. SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial. (25th January 2022)

87. Skin testing with different food formulations in pediatric patients with eosinophilic esophagitis. Issue 3 (12th December 2019)